Williams et al.
TPAP Oxidation Procedure: Preparation of 4-Methyl-N-(2-
ethylidenecyclopentane)-N-(3-oxopropyl)benzenesulfonamide (4c).
Solid TPAP (5 mol %) was added in one portion to a stirred mixture
of N-(3-hydroxypropyl)-4-methyl-N-(2-ethylidenecyclopentane)-
benzenesulfonamide (0.20 g, 0.60 mmol), N-methylmorpholine
N-oxide (0.109 g, 0.90 mmol), and powdered 4 Å molecular sieves
(0.50 g) in CH2Cl2 (10 mL). The reaction mixture was stirred for
75 min and then filtered through silica, eluting with CH2Cl2. The
residue was dried over MgSO4 and concentrated in vacuo. Flash
column chromatography (silica; eluent 2:3 ethyl acetate:petroleum
ether) afforded 4-methyl-N-(2-ethylidenecyclopentane)-N-(3-oxo-
propyl)benzenesulfonamide (4c) (0.17 g, 85%) as a colorless oil:
46.7, 63.0, 112.2, 127.6, 129.6, 133.4, 143.4, 143.8; MS (CI) m/z
296 ([M + H]+, 100%), 278 (4), 257 (5), 189 (8), 143 (13), 124
(15), 105 (4), 79 (11). Anal. Calcd for C15H21NO3S: C, 60.99; H,
7.17; N, 4.74. Found: C, 61.0; H, 7.1; N, 4.6. Further elution
afforded (3S*,4S*)-3-isopropenyl-1-(toluene-4-sulfonyl)piperidin-4-
ol (7a) (4 mg, 4%) as a white crystalline solid, data as above.
Typical Procedure for the Prins-Type Cyclization with HCl-
Saturated CH2Cl2: Preparation of (3R*,4S*)-3-(1-Benzyl-2-
phenylvinyl)-1-(toluene-4-sulfonyl)piperidin-4-ol (6f). Anhydrous
HCl gas was bubbled through a -78 °C solution of 4f (152 mg,
0.34 mmol) in CH2Cl2 for 30 min, followed by stirring at this
temperature for a further 6 h. Removal of the solvent in vacuo and
purification of the residue by flash column chromatography (silica;
eluent 2:1 petroleum ether:ethyl acetate) afforded (3R*,4S*)-3-(1-
benzyl-2-phenylvinyl)-1-(toluene-4-sulfonyl)piperidin-4-ol (6f) (108
mg, 71%) as a white crystalline solid: mp 129-130 °C; Rf 0.38;
1
Rf 0.51; IR (neat) 2947, 2361, 1720, 1450, 1335, 1157 cm-1; H
NMR (300 MHz, CDCl3) δ 1.54-1.66 (m, 4H), 2.13-2.15 (m,
2H), 2.16-2.20 (m, 2H), 2.42 (s, 3H), 2.80 (t, J ) 7.0 Hz, 2H),
3.37 (t, J ) 7.0 Hz, 2H), 3.75 (d, J ) 7.4 Hz, 2H), 5.08-5.15 (m,
1H), 7.30 (d, J ) 8.1 Hz, 2H), 7.67 (d, J ) 8.1 Hz, 2H), 9.75 (s,
1H); 13C NMR (75 MHz, CDCl3) δ 21.5, 25.9, 26.2, 28.8, 33.8,
41.1, 44.0, 48.0, 114.1, 127.3, 129.7, 136.5, 143.3, 149.2, 200.5;
MS (ES) m/z 344 (100%, [M + Na]+).
1
IR (CDCl3) 3438, 3026, 1644, 1493, 1338, 1161 cm-1; H NMR
(300 MHz, CDCl3) δ 1.62-1.72 (m, 1H), 1.74-1.86 (m, 1H), 2.48
(s, 3H), 2.55 (dt, J ) 2.9, 11.4 Hz, 1H), 2.67 (t, J ) 11.4 Hz, 1H),
3.19-3.24 (m, 1H), 3.29-3.38 (m, 1H,), 3.47-3.54 (m, 1H), 3.62
(s, 2H), 4.00 (s, 1H), 6.46 (s, 1H), 7.22 (d, J ) 7.0 Hz, 2H), 7.27-
7.32 (m, 6H), 7.33-7.44 (m, 4H), 7.45 (d, J ) 8.1 Hz, 2H); 13C
NMR (75 MHz, CDCl3) δ 21.5, 32.8, 40.2, 41.8, 42.5, 44.6, 67.7,
126.5, 126.8, 127.6, 128.4, 128.5, 128.7, 128.9, 129.6, 132.1, 133.0,
137.4 139.6, 140.4, 143.3; MS (ES) m/z 470 (100%, [M + Na]+).
Anal. Calcd for C27H29NO3S: C, 72.45; H, 6.53; N, 3.13. Found:
C, 72.5; H, 6.6; N, 2.9.
Typical Procedure for the Ene-Type Cyclization: Prepara-
tion of (3S*,4S*)-3-Isopropenyl-1-(toluene-4-sulfonyl)piperidin-
4-ol (7a). Methyl aluminum dichloride (1 M solution in hexanes,
0.34 mL, 0.34 mmol) was added to a solution of aldehyde 4a (100
mg, 0.34 mmol) in chloroform (10 mL). The resulting mixture was
heated under reflux for 16 h, after which it was quenched by
addition of water. The aqueous phase was then extracted with
diethyl ether and the combined organic phases washed with brine,
dried over MgSO4, and evaporated in vacuo to leave a colorless
oil that was purified by flash column chromatography (silica; eluent
2:1 petroleum ether:ethyl acetate) to give first (3R*,4S*)-3-isopro-
penyl-1-(toluene-4-sulfonyl)piperidin-4-ol (6a) (6 mg, 6%) as a
white crystalline solid, data as below. Further elution afforded
(3S*,4S*)-3-isopropenyl-1-(toluene-4-sulfonyl)piperidin-4-ol (7a) (74
mg, 74%) as a white crystalline solid: mp 149-151 °C (from
petroleum ether/ethyl acetate); Rf 0.24; IR (neat) 3391, 2920, 2904,
Typical Procedure for the Prins-Type Cyclization-Elimina-
tion with HCl-Saturated CH2Cl2 Followed by Ammonia: Prepa-
ration of (3R*,4S*)-3-Cyclohex-1-enyl-1-(toluene-4-sulfonyl)-
piperidin-4-ol (6d). Anhydrous HCl gas was bubbled through a
-78 °C solution of 4d (50 mg, 1.48 mmol) in CH2Cl2 for 30 min,
followed by stirring at this temperature for a further 2 h. The solvent
was removed in vacuo and the residue dissolved in THF (10 mL).
Concentrated aqueous ammonia was added (10 mL) and the mixture
was stirred for 18 h. Following removal of the THF in vacuo the
aqueous phase was extracted with CH2Cl2 and the combined organic
phases washed with brine, dried over MgSO4, and evaporated in
vacuo. Purification of the residue by flash column chromatography
(silica; eluent 2:1 petroleum ether:ethyl acetate) afforded (3R*,4S*)-
3-cyclohex-1-enyl-1-(toluene-4-sulfonyl)piperidin-4-ol (6d) (35 mg,
70%) as a white crystalline solid: mp 94-95 °C (from petroleum
ether/ethyl acetate); Rf 0.62; IR (CDCl3) 2910, 2360, 1670, 1590,
1
1647, 1597, 1458, 1334, 1304, 1157 cm-1; H NMR (500 MHz,
CDCl3) δ 1.58-1.68 (m, 1H), 1.71 (s, 3H), 1.85 (br s, 1H), 2.01-
2.06 (m, 1H), 2.17-2.27 (m, 2H), 2.37 (dt, J ) 2.8, 12.4 Hz, 1H),
2.43 (s, 3H), 3.44 (dt, J ) 4.5, 10.1 Hz, 1H), 3.75-3.77 (m, 1H),
3.81-3.86 (m, 1H), 4.89 (s, 1H), 5.01 (s, 1H), 7.32 (d, J ) 8.0
Hz, 2H), 7.64 (d, J ) 8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3)
δ 20.6, 21.5, 32.5, 45.0, 48.8, 51.6, 69.4, 114.7, 127.6, 129.7, 133.6,
142.4, 143.6; MS (CI) m/z 296 ([M + H]+, 100%), 278 (4), 247
(5), 189 (5), 143 (10), 124 (8), 79 (4), 69 (10). Anal. Calcd for
C15H21NO3S: C, 60.99; H, 7.17; N, 4.74. Found: C, 61.0; H, 7.1;
N, 4.6.
1
1334, 1161 cm-1; H NMR (300 MHz, CDCl3) δ 1.48-1.65 (m,
4H), 1.82-2.06 (m, 5H), 2.25-2.30 (m, 1H), 2.43 (s, 3H), 2.51-
2.61 (m, 2H), 3.50-3.60 (m, 2H), 3.91-3.93 (m, 1H), 5.31 (s,
1H), 7.32 (d, J ) 8.5 Hz, 2H), 7.65 (d, J ) 8.5 Hz, 2H); 13C NMR
(75 MHz, CDCl3) δ 21.5, 22.3, 22.8, 25.2, 28.6, 31.0, 40.6, 43.4,
46.9, 63.2, 123.6, 127.6, 129.7, 133.5, 136.2, 143.4; MS (ES) m/z
358 ([M + Na]+, 100%). Anal. Calcd for C18H25NO3S: C, 64.45;
H, 7.51; N, 4.18. Found: C, 64.5; H, 7.8; N, 4.0.
Typical Procedure for the Prins-Type Cyclization with
Concentrated Hydrochloric Acid: Preparation of (3R*,4S*)-3-
Isopropenyl-1-(toluene-4-sulfonyl)piperidin-4-ol (6a). Concen-
trated hydrochloric acid (37%, 0.10 mL, 1.02 mmol) was added to
a solution of aldehyde 4a (100 mg, 0.34 mmol) in CH2Cl2 (10 mL)
at -78 °C. The resulting mixture was stirred at -78 °C for 16 h,
after which it was quenched by addition of water. The aqueous
phase was then extracted with diethyl ether and the combined
organic phases washed with brine, dried over MgSO4, and
evaporated in vacuo to leave a colorless oil that was purified by
flash column chromatography (silica; eluent 2:1 petroleum ether:
ethyl acetate) to give (3R*,4S*)-3-isopropenyl-1-(toluene-4-sulfonyl)-
piperidin-4-ol (6a) (79 mg, 79%) as a white crystalline solid: mp
89-91 °C (from petroleum ether/ethyl acetate); Rf 0.36; IR (neat)
Typical Procedure for Removal of the p-Toluenesulfonyl
Group: Preparation of (3R*,4S*)-3-Cyclohept-1-enylpiperidin-
4-ol (22e). To a solution of 6e (62 mg, 0.18 mmol) in THF (0.8
mL) at -78 °C was added sodium naphthalenide (0.8 mL of 1 M
solution in THF). After 5 min the reaction was quenched by the
addition of MeOH (0.3 mL) and then allowed to warm to ambient
temperature. The reaction mixture was then diluted with H2O and
acidified to pH 1 with 3 M HCl. The aqueous layer was washed
with Et2O, basified to pH 9 with 3 M NaOH, and extracted with
EtOAc. The combined organic extracts were washed with brine,
dried over MgSO4, and concentrated in vacuo to yield (3R*,4S*)-
3-cyclohept-1-enylpiperidin-4-ol (22e) (25 mg, 71%) as a colorless
1
3519, 2920, 2904, 1651, 1597, 1447, 1323, 1304, 1157 cm-1; H
1
oil: IR (thin film) 3020, 2925, 1522, 1216, 756 cm-1; H NMR
NMR (500 MHz, CDCl3) δ 1.50 (br s, 1H), 1.77 (s, 3H), 1.81-
1.95 (m, 2H), 2.37 (d, J ) 12.1 Hz, 1H), 2.42 (s, 3H), 2.55-2.62
(m, 2H), 3.55-3.59 (m, 2H), 3.96 (d, J ) 2.2 Hz, 1H), 4.58 (s,
1H), 4.96 (s, 1H), 7.31 (d, J ) 8.1 Hz, 2H), 7.64 (d, J ) 8.1 Hz,
2H); 13C NMR (125 MHz, CDCl3) δ 21.5, 22.8, 31.1, 40.5, 43.5,
(300 MHz, CDCl3) δ 1.29-1.43 (m, 2H), 1.44-1.60 (m, 2H),
1.62-1.80 (m, 2H), 1.86-1.95 (m, 1H), 2.03-2.29 (m, 5H), 2.68-
3.03 (m, 5H), 4.00 (br s, 1H), 5.50 (t, J ) 6.3 Hz, 1H); 13C NMR
(75 MHz, CDCl3) δ 29.3, 29.5, 30.6, 34.3, 34.9, 35.8, 42.5, 45.9,
2470 J. Org. Chem., Vol. 71, No. 6, 2006